Thiruvananthapuram
08043694458
+918209542042

GLICLAGLAZE TRIO 40/0.3

Diabetic Range by Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), Voglibose IP (0.3 mg)

GLICLAGLAZE TRIO 40/0.3

INR 134 INR 192
In stockcod available
Phone Number

Email Address boost@sterispharma.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Thiruvananthapuram, Kerala, India

Thiruvananthapuram, India, 0

Description

GLICLAGLAZE TRIO 40/0.3 is a prescription medication used for managing type 2 diabetes. It contains a combination of three active ingredients—Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), and Voglibose IP (0.3 mg)—each targeting different pathways to help control blood sugar levels. Key Benefits: Provides comprehensive blood sugar control for patients with type 2 diabetes. Reduces fasting and post-meal glucose levels. Lowers the risk of complications associated with high blood sugar, such as cardiovascular issues and neuropathy. How Does It Work? Gliclazide enhances insulin secretion from the pancreas. Metformin decreases glucose production in the liver and improves insulin sensitivity. Voglibose slows the breakdown of carbohydrates in the intestines, minimizing sudden spikes in blood sugar levels after meals. Directions for Use: Take this medication as directed by your healthcare provider, typically once or twice daily with meals. Swallow the tablet whole with water. Do not crush or chew the tablet. Regularly monitor your blood sugar levels as advised by your doctor. Side Effects: Common: Nausea, diarrhea, stomach pain, and low blood sugar (hypoglycemia). Less Common: Headaches, dizziness, and mild gastrointestinal discomfort. Rare but Severe: Severe hypoglycemia, lactic acidosis (with metformin), or allergic reactions.

Keywords

Other Medicines

view all